Devissaguet M - Search Results

1

Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.

Lecocq B, Funck-Brentano C, Lecocq V, Ferry A, Gardin ME, Devissaguet M, Jaillon P. Lecocq B, et al. Among authors: devissaguet m. Clin Pharmacol Ther. 1990 Mar;47(3):397-402. doi: 10.1038/clpt.1990.45. Clin Pharmacol Ther. 1990. PMID: 2311339 Clinical Trial.

2

Pharmacokinetics of perindopril and its metabolites in healthy volunteers.

Devissaguet JP, Ammoury N, Devissaguet M, Perret L. Devissaguet JP, et al. Among authors: devissaguet m. Fundam Clin Pharmacol. 1990;4(2):175-89. doi: 10.1111/j.1472-8206.1990.tb00486.x. Fundam Clin Pharmacol. 1990. PMID: 2351367 Clinical Trial.

3

Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats.

Levy BI, Michel JB, Salzmann JL, Poitevin P, Devissaguet M, Scalbert E, Safar ME. Levy BI, et al. Among authors: devissaguet m. Am J Cardiol. 1993 Jun 24;71(17):8E-16E. doi: 10.1016/0002-9149(93)90946-a. Am J Cardiol. 1993. PMID: 8328370

4

Beneficial effect of perindopril, an angiotensin-converting enzyme inhibitor, on left ventricular performance and noradrenaline myocardial content during cardiac failure development in the rat.

Ribuot C, Mossiat C, Devissaguet M, Rochette L. Ribuot C, et al. Among authors: devissaguet m. Can J Physiol Pharmacol. 1990 Dec;68(12):1548-51. doi: 10.1139/y90-235. Can J Physiol Pharmacol. 1990. PMID: 2150787

5

Remodeling of heart and arteries by chronic converting enzyme inhibition in spontaneously hypertensive rats.

Levy BI, Michel JB, Salzmann JL, Devissaguet M, Safar ME. Levy BI, et al. Among authors: devissaguet m. Am J Hypertens. 1991 Mar;4(3 Pt 2):240S-245S. doi: 10.1093/ajh/4.3.240s. Am J Hypertens. 1991. PMID: 1828353

6

Effects of chronic converting enzyme inhibition on the structure and function of large arteries in the rat.

Levy BI, Michel JB, Salzmann JL, Devissaguet M, Camilleri JP, Safar ME. Levy BI, et al. Among authors: devissaguet m. Clin Exp Hypertens A. 1989;11 Suppl 2:487-98. Clin Exp Hypertens A. 1989. PMID: 2605798

7

Renal effects of perindoprilat, an angiotensin-converting enzyme inhibitor, in the anesthetized dog.

Schmidt M, Krieger JP, Devissaguet M, Imbs JL. Schmidt M, et al. Among authors: devissaguet m. J Cardiovasc Pharmacol. 1989 Feb;13(2):283-90. doi: 10.1097/00005344-198902000-00017. J Cardiovasc Pharmacol. 1989. PMID: 2468959

8

Angiotensin converting enzyme (ACE) inhibitors in experimental hypertension: influence on heart and arteries.

Levy BI, Salzmann JL, Devissaguet M, Safar ME, Michel JB. Levy BI, et al. Among authors: devissaguet m. Basic Res Cardiol. 1991;86 Suppl 1:43-53. Basic Res Cardiol. 1991. PMID: 1827984

9

Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor.

Grislain L, Mocquard MT, Dabe JF, Bertrand M, Luijten W, Marchand B, Resplandy G, Devissaguet M. Grislain L, et al. Among authors: devissaguet m. Xenobiotica. 1990 Aug;20(8):787-800. doi: 10.3109/00498259009046893. Xenobiotica. 1990. PMID: 2219962

10

[Effects of chronic inhibition of converting enzymes on the structure and function of the large arterial trunks in rats].

Lévy BI, Michel JB, Salzmann JL, Devissaguet M, Camilleri JP, Safar ME. Lévy BI, et al. Among authors: devissaguet m. Arch Mal Coeur Vaiss. 1989 May;82 Spec No 1:25-30. Arch Mal Coeur Vaiss. 1989. PMID: 2505710 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters